ProteinQure is a revenue-generating software platform for computational protein drug discovery. We combine molecular simulations, machine learning, and quantum computing to do the structure-based design of drugs. These physics-based methods make us less dependent on large data sets and that allows us to explore novel protein structures and interactions. We use our computational platform (as well as wetlab validation) to solve our partners drug design challenges and deliver new therapeutic candidates.
We have a very diverse team of multi-disciplinary scientists and engineers. We are based in Toronto, Canada and are funded by top tier venture firms. If you are interested in building the next generation of computational biology tools we hope you will join us.
We have a very diverse team of multi-disciplinary scientists and engineers. We are based in Toronto, Canada and are funded by top tier venture firms. If you are interested in building the next generation of computational biology tools we hope you will join us.
Location: Canada, Ontario, Toronto
Employees: 11-50
Total raised: $15M
Founded date: 2017
Investors 5
| Date | Name | Website |
| - | Creative D... | creativede... |
| - | Felicis Ve... | felicis.co... |
| - | Endless Fr... | endlessfro... |
| - | Golden Ven... | golden.ven... |
| - | Esalen Ven... | esalenvent... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 03.06.2025 | Series A | $11M | - |
| 29.07.2019 | Seed | $4M | - |
Mentions in press and media 10
| Date | Title | Description |
| 04.06.2025 | ProteinQure's $11 Million Leap: A New Era for Peptide Therapeutics | In the world of biotechnology, innovation is the lifeblood. ProteinQure, a Toronto-based company, has just taken a significant step forward by securing $11 million in Series A funding. This financial boost, led by Tom Williams of Heron Rock... |
| 03.06.2025 | ProteinQure: $11 Million Series A Raised For Computational Peptide Therapeutics | ProteinQure, a computational peptide therapeutics company, announced the closing of an $11 million Series A financing round. The funding round was led by Tom Williams of Heron Rock Fund, with participation from Golden Ventures, Kensington C... |
| 28.05.2025 | ProteinQure Closes $11M in Series A Financing | ProteinQure, a Toronto, Canada-based biotechnology company developing computational peptide therapeutics, raised $11M in Series A funding. The round was led by Tom Williams of Heron Rock Fund, with participation from Golden Ventures, Kensin... |
| 27.05.2025 | ProteinQure (Life Sciences, '20-21) Nears the Clinic with Peptide Platform as it Raises $11M Series A | - |
| 05.09.2022 | What is reinforcement learning? How AI trains itself | Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here. Table of contents What are some useful open-source options for reinforcement learning? How do major providers handle re... |
| 23.12.2019 | MIT Technology Review presents the Innovators Under 35 Europe 2019 | Since 1999, MIT Technology Review recognizes the young innovators and most talented entrepreneurs from different countries who are developing new technologies to help solve the problems that affect our society nowadays. These young bright m... |
| 31.07.2019 | ProteinQure Raises $4M in seed Funding | ProteinQure, a Toronto, Canada-based protein therapeutics company, raised $4M in seed funding. The round was led by Felicis Ventures with participation from 8VC, Golden Ventures, iNovia, Global Founders Capital and angel investor Tom Willia... |
| 29.07.2019 | Daily funding roundup - July 29th, 2019 | BabySparks raised $2M; ProteinQure landed $4M; Ethyca secured $4.2M; Pyze closed $4.6M BabySparks: BabySparks is building tools and programs to help parents engage their babies and toddlers in the critical areas of early development. BabySp... |
| 29.07.2019 | ProteinQure raises $5.2 million CAD for protein-focused drug design platform | Toronto-based biotechnology startup ProteinQure has raised a $5.2 million CAD ($4 million USD) seed round for its computational protein drug design platform. The round was led by California-based Felicis Ventures, with participation from 8V... |
| - | ProteinQure | “ProteinQure is a biotech company focused on the design of novel exotic peptides with broad therapeutic applications.” |